About PBYI Dividend Returns
Puma Biotechnology, Inc. (PBYI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of PBYI over the past year?
Puma Biotechnology, Inc. (PBYI) delivered a return of 59.22% over the past year. Since PBYI does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in PBYI be worth today?
A $10,000 investment in Puma Biotechnology, Inc. one year ago would be worth $15,922 today, representing a gain of $5,922.
Q3Does PBYI pay dividends?
Puma Biotechnology, Inc. (PBYI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PBYI, the total return equals the price-only return.
Q4Did PBYI beat the S&P 500?
Yes, Puma Biotechnology, Inc. (PBYI) outperformed the S&P 500 by 43.77 percentage points over the past year. PBYI delivered a total return of 59.22%, compared to the S&P 500's 15.45%. This 43.77pp alpha means investors in PBYI earned more than a passive S&P 500 index fund.
Q5What is PBYI's worst drawdown?
Puma Biotechnology, Inc. (PBYI) experienced a maximum drawdown of -25.78% over the past year, declining from its peak on 2026-02-25 to its trough on 2026-02-27. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is PBYI's long-term total return over 10, 20, or 30 years?
Puma Biotechnology, Inc. (PBYI) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -87.3% (-18.6% CAGR) — $10,000 would have grown to $1,273. Over 20 years: -59.3% total return (-4.4% CAGR) — $10,000 → $4,071. Over 30 years: -59.3% total return (-3.0% CAGR) — $10,000 → $4,071. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was PBYI's best and worst year?
Puma Biotechnology, Inc.'s best calendar year was 2013 with a total return of 444.6%. Its worst year was 2018 with a total return of -78.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 522.6 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).